These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34158520)

  • 41. Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient.
    Krantz BA; Finkelstein A; Collier RJ
    J Mol Biol; 2006 Feb; 355(5):968-79. PubMed ID: 16343527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ion conductance of the stem of the anthrax toxin channel during lethal factor translocation.
    Schiffmiller A; Finkelstein A
    J Mol Biol; 2015 Mar; 427(6 Pt A):1211-23. PubMed ID: 24996036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A kinetic analysis of protein transport through the anthrax toxin channel.
    Basilio D; Kienker PK; Briggs SW; Finkelstein A
    J Gen Physiol; 2011 Jun; 137(6):521-31. PubMed ID: 21624946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus.
    Milne JC; Blanke SR; Hanna PC; Collier RJ
    Mol Microbiol; 1995 Feb; 15(4):661-6. PubMed ID: 7783638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disulfide bonds in the ectodomain of anthrax toxin receptor 2 are required for the receptor-bound protective-antigen pore to function.
    Sun J; Collier RJ
    PLoS One; 2010 May; 5(5):e10553. PubMed ID: 20479891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peptide Probes Reveal a Hydrophobic Steric Ratchet in the Anthrax Toxin Protective Antigen Translocase.
    Colby JM; Krantz BA
    J Mol Biol; 2015 Nov; 427(22):3598-3606. PubMed ID: 26363343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of N-terminal fragments of anthrax edema factor (EF(N)) and lethal factor (LF(N)) to the protective antigen pore.
    Leuber M; Kronhardt A; Tonello F; Dal Molin F; Benz R
    Biochim Biophys Acta; 2008 Jun; 1778(6):1436-43. PubMed ID: 18243126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism.
    Kintzer AF; Sterling HJ; Tang II; Williams ER; Krantz BA
    PLoS One; 2010 Nov; 5(11):e13888. PubMed ID: 21079738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma.
    Kintzer AF; Sterling HJ; Tang II; Abdul-Gader A; Miles AJ; Wallace BA; Williams ER; Krantz BA
    J Mol Biol; 2010 Jun; 399(5):741-58. PubMed ID: 20433851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lethal factor unfolding is the most force-dependent step of anthrax toxin translocation.
    Thoren KL; Worden EJ; Yassif JM; Krantz BA
    Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21555-60. PubMed ID: 19926859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anthrax toxin channel: What we know based on over 30 years of research.
    Liu W; Nestorovich EM
    Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183715. PubMed ID: 34332985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anthrax Toxin: Model System for Studying Protein Translocation.
    Krantz BA
    J Mol Biol; 2024 Apr; 436(8):168521. PubMed ID: 38458604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Translocation of Non-Canonical Polypeptides into Cells Using Protective Antigen.
    Rabideau AE; Liao X; Akçay G; Pentelute BL
    Sci Rep; 2015 Jul; 5():11944. PubMed ID: 26178180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure and function of anthrax toxin.
    Lacy DB; Collier RJ
    Curr Top Microbiol Immunol; 2002; 271():61-85. PubMed ID: 12224524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
    Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
    Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine.
    Wu G; Hong Y; Guo A; Feng C; Cao S; Zhang CC; Shi R; Tan Y; Liu Z
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4750-7. PubMed ID: 20713663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A receptor-based switch that regulates anthrax toxin pore formation.
    Pilpa RM; Bayrhuber M; Marlett JM; Riek R; Young JA
    PLoS Pathog; 2011 Dec; 7(12):e1002354. PubMed ID: 22174672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anthrax toxin: receptor binding, internalization, pore formation, and translocation.
    Young JA; Collier RJ
    Annu Rev Biochem; 2007; 76():243-65. PubMed ID: 17335404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cryo-EM structures reveal translocational unfolding in the clostridial binary iota toxin complex.
    Yamada T; Yoshida T; Kawamoto A; Mitsuoka K; Iwasaki K; Tsuge H
    Nat Struct Mol Biol; 2020 Mar; 27(3):288-296. PubMed ID: 32123390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.